2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hodgkin Disease
50
Lymphoma
45
Testicular Neoplasms
13
Teratoma
12
HIV Infections
12
Acquired Immunodeficiency Syndrome
11
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, Non-Hodgkin
9
Head and Neck Neoplasms
8
Endodermal Sinus Tumor
8
Testicular Germ Cell Tumor
7
Sarcoma, Kaposi
7
Neoplasms
7
Carcinoma, Embryonal
7
Seminoma
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Follicular
6
Ovarian Neoplasms
5
Ovarian Germ Cell Cancer
5
Recurrence
4
Neoplasms, Germ Cell and Embryonal
4
Neoplasm Metastasis
4
Carcinoma, Squamous Cell
4
Vulvar Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Breast Neoplasms
3
Teratoma, Testicular
2
Skin Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Drug-Related Side Effects and Adverse Reactions
2
Interventions
Oxaliplatin
271
Fluorouracil
268
Capecitabine
234
Leucovorin
209
Irinotecan
152
Radiotherapy
138
Bevacizumab
114
Cetuximab
82
Surgical Procedures, Operative
51
Folfox protocol
48
Neoadjuvant Therapy
45
Drug Therapy
43
Radiation
42
Chemotherapy, Adjuvant
34
Chemoradiotherapy
34
Panitumumab
27
Magnetic Resonance Spectroscopy
26
XELOX
25
Radiotherapy, Intensity-Modulated
23
Biopsy
20
Surveys and Questionnaires
18
Laparoscopy
18
Proctectomy
17
Floxuridine
17
Early Intervention, Educational
16
Nivolumab
15
Immunohistochemistry
15
Gene Expression Profiling
15
Gemcitabine
15
pembrolizumab
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Bleomycin
×
Clear all
NCT03040180
2019-01-25
nECT
Zealand University Hospital
Phase 2
Unknown
40 enrolled